Skip to content

What changed

From · Plenary report · 19 Mar 2024 A-9-2024-0133 on discharge in respect of the implementation of the budget of the European Medicines Agency for the financial year 2022
To · Adopted text · 11 Apr 2024 TA-9-2024-0245 Discharge 2022: European Medicines Agency

The changes to the text itself, in document order. Cover page, citations (“having regard to …”), standard resolution paragraphs and punctuation-only edits are left out — they are in “Show every difference”.

Change #1

2. PROPOSAL FOR A EUROPEAN PARLIAMENT DECISION

2. European Parliament decision of 11 April 2024 on the closure of the accounts of the European Medicines Agency for the financial year 2022 (2023/2156(DEC))

on the closure of the accounts of the European Medicines Agency for the financial year 2022

Change #2

3. MOTION FOR A EUROPEAN PARLIAMENT RESOLUTION

3. European Parliament resolution of 11 April 2024 with observations forming an integral part of the decision on discharge in respect of the implementation of the budget of the European Medicines Agency for the financial year 2022 (2023/2156(DEC))

with observations forming an integral part of the decision on discharge in respect of the implementation of the budget of the European Medicines Agency for the financial year 2022

Change #3

28. Observes that in 2022 two Breach-of-Trust (BoT)BoT procedures were initiated for experts; notes that one case involved a committee member failing to disclose a lecture honorarium, resulting in revised declarations and a three-year restriction and the second case concerned a committee member omitting a close family member interest, leading to a 9-month restriction from the Agency’s activities;

Change #4

43. Refers, for other observations of a cross-cutting nature accompanying its decision on discharge, to its resolution of ...11 April 2024 on the performance, financial management and control of the agencies.